Pancreatic Cancer Research

ResearcherOsaka City UniversityActive in the last 2 years

Kohei Nishio

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-0480-7640; OpenAlex author ID A5103153066. Sources: OpenAlex.

Their work

Papers
10
Trials
0
Grants
0
Labs led
0
Collaborators
17
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: 1 paper · 2017: 2 papers · 2018: none · 2019: none · 2020: 2 papers · 2021: none · 2022: 1 paper · 2023: 1 paper · 2024: 1 paper · 2025: none · 2026: 1 paper

Papers 10

  1. Preoperative Serum Total Cholesterol Predicts Adjuvant Chemotherapy Completion After Pancreaticoduodenectomy for Pancreatic Cancer. Co-author DOI 10.21873/anticanres.18203↗
  2. [Devising a Surgical Approach Using the Intestinal Derotation Procedure for Locally Advanced Pancreatic Cancer]. Co-author PMID 39948948↗
  3. Pancreaticoduodenectomy with celiac artery resection (PD-CAR) for unresctable locally advanced pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s00423-023-02860-1↗
  4. Optimal Organ for Patient-derived Xenograft Model in Pancreatic Cancer and Microenvironment that Contributes to Success. Co-author DOI 10.21873/anticanres.15718↗
  5. [Pancreatic Cancer with Hemobilia after Biliary Self-Expandable Metallic Stent Placement during Neoadjuvant Chemotherapy-A Case Report]. Co-author PMID 32381875↗
  6. [Successful Conversion Surgery for Pancreatic Cancer with Sister Mary Joseph's Nodule-A Case Report]. Co-author PMID 33468976↗
  7. Analysis of the origin of anaplastic pancreatic cancer and the mechanism of its dedifferentiation. Co-author DOI 10.1002/jhbp.429↗
  8. Preoperative predictors for early recurrence of resectable pancreatic cancer. Co-author DOI 10.1186/s12957-016-1078-z↗
  9. Establishment and characterization of new cell lines of anaplastic pancreatic cancer, which is a rare malignancy: OCUP-A1 and OCUP-A2. Co-author DOI 10.1186/s12885-016-2297-y↗
  10. Clinical and pathological features of five-year survivors after pancreatectomy for pancreatic adenocarcinoma. Co-author DOI 10.1186/1477-7819-12-360↗

Closest collaborators

The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Hiroji Shinkawa · 4 shared papers, 2022–2026 · strength 0.79
  2. Kenjiro Kimura · 7 shared papers, 2014–2024 · strength 0.73
  3. Takeaki Ishizawa · 3 shared papers, 2023–2026 · strength 0.66
  4. Ryota Tanaka · 3 shared papers, 2022–2026 · strength 0.62
  5. Ryosuke Amano · 6 shared papers, 2014–2023 · strength 0.55
  6. Kosuke Hatta · 2 shared papers, 2024–2026 · strength 0.48
  7. Shigeaki Kurihara · 2 shared papers, 2024–2026 · strength 0.48
  8. Akihiro Murata · 4 shared papers, 2014–2020 · strength 0.28
  9. Sadaaki Yamazoe · 4 shared papers, 2014–2017 · strength 0.24
  10. Masaichi Ohira · 4 shared papers, 2014–2017 · strength 0.24
  11. Kosei Hirakawa · 4 shared papers, 2014–2017 · strength 0.24
  12. Akishige Kanazawa · 2 shared papers, 2020 · strength 0.19
  13. Masakazu Yashiro · 2 shared papers, 2016–2022 · strength 0.19
  14. Kotaro Miura · 3 shared papers, 2014–2017 · strength 0.16
  15. Shoji Kubo · 1 shared paper, 2022 · strength 0.13
  16. Shimpei Eguchi · 1 shared paper, 2022 · strength 0.13
  17. Toshiki Hirakawa · 1 shared paper, 2014 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.